TransMedics (TMDX) Income towards Parent Company (2018 - 2026)

TransMedics' Income towards Parent Company history runs 9 years deep, the most recent figure standing at $7.3 million for Q1 2026.

• In Q1 2026, Income towards Parent Company fell 71.51% year-over-year to $7.3 million; the TTM figure through Mar 2026 stood at $85.1 million (up 73.13% YoY), while the FY2025 annual figure was $83.9 million, up 135.26% from the prior year.
• Income towards Parent Company was $7.3 million for Q1 2026 at TransMedics, down from $18.6 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $34.9 million in Q2 2025 to a low of -$25.4 million in Q3 2023.
• Historically, Income towards Parent Company has averaged $6.5 million across 5 years, with a median of $7.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Income towards Parent Company tumbled 242.34% in 2023, then jumped 1318.18% in 2024.
• A 5-year view of Income towards Parent Company shows it stood at -$6.7 million in 2022, then soared by 537.51% to $29.4 million in 2023, then plunged by 75.94% to $7.1 million in 2024, then soared by 162.7% to $18.6 million in 2025, then plunged by 60.63% to $7.3 million in 2026.
• The last three Income towards Parent Company figures came in at $7.3 million (Q1 2026), $18.6 million (Q4 2025), and $24.3 million (Q3 2025), per Business Quant data.